Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-129143

Chief Executive Officer sold 26,198 shares at $50.07 ($1,311,826)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-25 Sale : show line 1 in the form 10b5-1 −26,198 $50.07 $1,311,826 2,918,326 I
Open-market sales · 26,198 sh · avg $50.07 · $1,311,826
Loading xslF345X06/ownership.xml…